Thyroid-associated ophthalmopathy (TAO) has a major effect on the two
compartments of the retroorbital (RO) space, leading to enlargement of
the extraocular muscles and other RO tissues. T lymphocyte infiltrati
on of RO tissue is a characteristic feature of TAO and there is curren
t interest in whether these T cells are specifically and selectively r
eactive to RO tissue itself. We recently established 18 T cell lines (
TCL) from RO adipose/connective tissue of six patients with severe TAO
by using IL-2, anti-CD3 antibodies and irradiated autologous peripher
al blood mononuclear cells (PBMC) to maintain the growth of T cells re
active to autologous RO tissue protein fractions. Here we report on th
e phenotype characteristics and cytokine gene expression profiles of t
hese orbital TCL and on their immunoreactivity to the organ-specific t
hyroid antigens thyrotropin receptor (TSH-R), thyroidal peroxidase (TP
O) and thyroglobulin (TG). Flow cytometry revealed that 10 TCL were pr
edominantly of CD4(+) phenotype, three being mostly CD8(+) and five ne
ither CD4(+) nor CD8(+). Analysis with reverse transcriptase polymeras
e chain reaction (RT-PCR) of cytokine gene expression revealed both Th
1- and Th2-like products in all TCL: IL-2 product (in 17 TCL), interfe
ron-gamma (IFN-gamma) (n = 10), tumour necrosis factor-beta (TNF-beta)
(n = 15), IL-4 (n = 12), IL-5 (n = 17), IL-6 (n = 13), TNF-alpha (n =
12) and IL-10 (n=4). Reactivity to thyroid antigens was observed only
in two TCL, the other 16 being uniformly unreactive. Although 10 out
of 18 RO tissue-reactive TCL were predominantly CD4(+) there were no s
ignificant relationships between TCL phenotype, cytokine gene profile,
magnitude of reactivity to RO tissue protein or the (rare) occurrence
of thyroid reactivity. The findings of both Th1- and Th2-like cytokin
e gene expression in all RO tissue-reactive TCL support the concept th
at TAO is a tissue-specific autoimmune disease, distinct immunological
ly from the thyroid, and involving both T cell and B cell autoimmune m
echanisms in disease pathogenesis.